☰
Filter by:
Using Mass Spectrometry for Oligonucleotide and Peptide Synthesis Assessment
BioPharMoore Episode 11: NIBRT x Thermo Fisher Scientific, Collaboration for Characterization
Why Does the Monoclonal Antibody Make Such an Ideal Biotherapeutic?
November 2, 2018 by Dr. Timothy Cross Read
From Me to You: The Gift of Ion Chromatography
December 20, 2017 by Dr. Rowan Moore Read
Trends in Biopharmaceutical Characterisation
October 30, 2017 by Dr. Timothy Cross Read
Bispecifics: Killing Two Birds with One Stone…
June 20, 2017 by Dr. Kelly Broster Read
Drive-thru McBiosimilars
May 10, 2017 by Dr. Kyle D'Silva Read
Well I Would Fly 5000 Miles, Then I Would Fly 5000 More
January 25, 2017 by Dr. Kyle D'Silva Read
Simplicity Is the Ultimate Sophistication
January 20, 2017 by Dr. Kelly Broster Read
Transitioning from Small to Large Molecule Quantitation – It Doesn’t Have to Be Difficult
January 16, 2017 by Dr. Debadeep Bhattacharyya Read
10 Pharma New Year’s Resolutions You Can Keep
January 11, 2017 by Dr. Rowan Moore Read
Card Games: How to Choose a Mass Spec for BioPharma
December 22, 2016 by Dr. Simon Cubbon Read
It’s In The Bag. Literally.
November 4, 2016 by Dr. Kyle D'Silva Read
Is Your Analytical Method Keeping Pace with Biopharmaceutical Development?
September 21, 2016 by Dr. Eric Niederkofler Read

Industries

Resources

Contributors

Terms and Conditions | Privacy Statement | Trademarks | Cookie Usage

© Copyright 2019 Thermo Fisher Scientific Inc. All rights reserved.